ResMed, Inc. Stock price

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
196.3 USD +1.11% Intraday chart for ResMed, Inc. +2.05% +14.13%
Sales 2024 * 4.64B Sales 2025 * 4.95B Capitalization 28.84B
Net income 2024 * 977M Net income 2025 * 1.16B EV / Sales 2024 * 6.35 x
Net Debt 2024 * 636M Net cash position 2025 * 203M EV / Sales 2025 * 5.79 x
P/E ratio 2024 *
30 x
P/E ratio 2025 *
25.8 x
Employees 10,140
Yield 2024 *
1%
Yield 2025 *
1.07%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.11%
1 week+2.05%
Current month+13.02%
1 month+8.48%
3 months+13.50%
6 months+32.08%
Current year+14.13%
More quotes
1 week
191.12
Extreme 191.12
196.75
1 month
170.56
Extreme 170.56
196.75
Current year
164.12
Extreme 164.1225
197.85
1 year
132.24
Extreme 132.24
243.52
3 years
132.24
Extreme 132.24
301.34
5 years
96.81
Extreme 96.81
301.34
10 years
43.76
Extreme 43.76
301.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 00-08-31
Founder 81 89-05-31
Director of Finance/CFO 51 -
Members of the board TitleAgeSince
Chief Executive Officer 51 00-08-31
Director/Board Member 76 04-12-31
Founder 81 89-05-31
More insiders
Date Price Change Volume
24-03-27 196.3 +1.11% 567,412
24-03-26 194.2 +0.45% 1,108,903
24-03-25 193.3 +0.68% 1,836,891
24-03-22 192 -0.89% 1,130,264
24-03-21 193.7 +0.70% 1,109,771

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
196.3 USD
Average target price
205 USD
Spread / Average Target
+4.40%
Consensus
  1. Stock
  2. Equities
  3. Stock ResMed, Inc. - Nyse